Related Experiment Videos
Rationale for the use of very-low-dose combinations as first-line treatment of hypertension
1Division of Clinical Pathophysiology and Medical Teaching, Department of Medicine, University Hospital, Lausanne, Switzerland. bwaeber@chuv.hospvd.ch
Insights
Managing hypertension is challenging, often requiring multiple medications. Fixed-dose combinations, especially very-low-dose ones, offer improved efficacy and tolerability for blood pressure control.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Hypertension management is complex, with many patients needing multiple antihypertensive drugs.
- Achieving target blood pressure (<140/90 mmHg) frequently necessitates combination therapy.
- Fixed-dose combinations are gaining popularity due to convenience and potential efficacy.
Purpose of the Study:
- To evaluate the role and benefits of fixed-dose combinations in hypertension management.
- To highlight the advantages of very-low-dose drug combinations for efficacy and tolerability.
Main Methods:
- Review of current therapeutic strategies for hypertension.
- Analysis of the pharmacological principles behind drug combinations.
- Assessment of the clinical profile of very-low-dose fixed-dose combinations.
Main Results:
- Combination therapy is often required to reach blood pressure goals.
- Fixed-dose combinations maximize antihypertensive efficacy by targeting different mechanisms.
- Very-low-dose combinations offer significant efficacy with minimal dose-dependent side effects.
Conclusions:
- Fixed-dose combinations are increasingly important in hypertension treatment.
- Very-low-dose combinations present a promising option for initiating treatment.
- These combinations offer a favorable balance of efficacy and tolerability.
Abstract:
The management of hypertension remains a difficult task, despite the availability of an increasing number of medications that decrease blood pressure by different mechanisms. In order to achieve a blood pressure less than 140/90 mmHg, most hypertensive patients require the co-administration of two or more drugs from different therapeutic classes. This explains why fixed-dose combinations are becoming increasingly popular. Combining drugs with different impacts on the cardiovascular system makes it possible to maximise the antihypertensive efficacy of the treatment regimen. The combination of very low doses of drugs that exhibit dose-dependent side effects leads to a marked gain in efficacy, with indiscernible side effects. During recent years, very-low-dose combinations have been developed. These combinations are very promising because of their excellent efficacy and tolerance profile. This has led to the recognition that such combinations might be a valuable option with which to initiate treatment in hypertensive patients.